These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 92102)

  • 21. [Drug-induced rhinitis--significant adverse effect].
    Buajordet M; Spigset O; Steinsvåg SK
    Tidsskr Nor Laegeforen; 2001 Aug; 121(18):2184-5. PubMed ID: 11571997
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pathologic conditions associated with drug-induced rhinitis].
    Milosević D; Janosević L; Dergenc R; Vasić M
    Srp Arh Celok Lek; 2004; 132(1-2):14-7. PubMed ID: 15227959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Overuse of nasal adrenergic agents--time for a warning, again!].
    Holmström M
    Lakartidningen; 2007 Feb 21-27; 104(8):612. PubMed ID: 17396466
    [No Abstract]   [Full Text] [Related]  

  • 24. Rhinitis during pregnancy and rhinitis medicamentosa.
    Lekas MD
    Otolaryngol Head Neck Surg; 1992 Dec; 107(6 Pt 2):845-8; discussion 849. PubMed ID: 1281917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Drug-induced rhinitis].
    Debain JJ
    Cah Med; 1970 Oct; 12(13):1087-9. PubMed ID: 4108591
    [No Abstract]   [Full Text] [Related]  

  • 26. [Daily administration of nose drops can cause chronic nasal congestion].
    Graf P; Hallén H
    Lakartidningen; 1996 Jan; 93(4):259-62. PubMed ID: 8569350
    [No Abstract]   [Full Text] [Related]  

  • 27. Rhinitis medicamentosa: a review of causes and treatment.
    Graf P
    Treat Respir Med; 2005; 4(1):21-9. PubMed ID: 15725047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rhinitis medicamentosa: a nationwide survey of Canadian otolaryngologists.
    Fowler J; Chin CJ; Massoud E
    J Otolaryngol Head Neck Surg; 2019 Dec; 48(1):70. PubMed ID: 31818321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rhinitis medicamentosa. An experimental histopathological and histochemical study.
    Elwany SS; Stephanos WM
    ORL J Otorhinolaryngol Relat Spec; 1983; 45(4):187-94. PubMed ID: 6192384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of Rhinitis Medicamentosa: A Systematic Review.
    Zucker SM; Barton BM; McCoul ED
    Otolaryngol Head Neck Surg; 2019 Mar; 160(3):429-438. PubMed ID: 30325708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained use of xylometazoline nasal spray shortens the decongestive response and induces rebound swelling.
    Graf P; Juto JE
    Rhinology; 1995 Mar; 33(1):14-7. PubMed ID: 7540314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Drug-induced rhinitis].
    Freyss G; Saint-Macary M
    Rev Prat; 1972 Jun; 22(18):2797-805. PubMed ID: 4119095
    [No Abstract]   [Full Text] [Related]  

  • 33. Rhinitis medicamentosa.
    Toohill RJ; Lehman RH; Grossman TW; Belson TP
    Laryngoscope; 1981 Oct; 91(10):1614-21. PubMed ID: 6169966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Corticosteroid is efficient against abuse of nasal decongestants].
    Graf P; Enerdal J; Hallén H
    Lakartidningen; 1998 Sep; 95(40):4344-6. PubMed ID: 9800453
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies of rhinitis medicamentosa.
    Wang JQ; Bu GX
    Chin Med J (Engl); 1991 Jan; 104(1):60-3. PubMed ID: 1879198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rhinitis medicamentosa.
    Black MJ; Remsen KA
    Can Med Assoc J; 1980 Apr; 122(8):881-4. PubMed ID: 6154514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predisposing factors of rhinitis medicamentosa: what can influence drug discontinuation?
    De Corso E; Mastrapasqua RF; Tricarico L; Settimi S; Di Cesare T; Mele DA; Trozzi L; Salonna G; Paludetti G; Galli J
    Rhinology; 2020 Jun; 58(3):233-240. PubMed ID: 31904029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Rhinitis medicamentosa: an increasing therapeutical problem].
    Betlejewski S
    Otolaryngol Pol; 1997; 51(1):53-7. PubMed ID: 9518316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment with xylometazoline (Otrivin) nosedrops over a six-week period.
    Petruson B
    Rhinology; 1981 Sep; 19(3):167-72. PubMed ID: 6171024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxic and drug-induced disorders in otolaryngology.
    Rutka J; Alberti PW
    Otolaryngol Clin North Am; 1984 Nov; 17(4):761-74. PubMed ID: 6083522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.